France Veterinary Reference Laboratory Market Overview, 2031

Key Insights

• France's veterinary reference laboratory market is undergoing steady transformation, supported by high pet ownership and a livestock sector that, while facing challenges, remains a major force within the European Union. According to data from the French pet food manufacturers' federation (FACCO), 60% of French households owned a pet in 2025, representing approximately 73.4 million companion animals. While down slightly from 75.1 million in 2024, the pet population remains significantly above pre-pandemic levels, having grown by 14.6% compared to 2018. Among companion animals, cats remain the most prevalent, with 16.6 million identified cats, followed by dogs at 9.6 million. The livestock sector is equally robust, with France maintaining its position as the EU's largest cattle-producing country, with a herd of approximately 16.2 million animals. This includes a dairy herd of around 3.6 million cows.
• The French veterinary reference laboratory market is underpinned by a highly sophisticated and accredited infrastructure. The Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES) operates a network of nine laboratories across 16 sites, employing over 600 scientists and technicians engaged in research and reference activities for animal health, food safety, and plant health. These laboratories are accredited by the Comité français d'accréditation (COFRAC) according to the NF EN ISO/CEI 17025 standard, ensuring the highest quality of diagnostic services. Key facilities include the Ploufragan-Plouzané-Niort Laboratory, which serves as a National Reference Laboratory (NRL) for a range of livestock diseases, and the Lyon Laboratory, which coordinates the RESAPATH surveillance network for antimicrobial resistance in pathogenic bacteria of animal origin.
• Regulatory oversight for veterinary diagnostics is rigorous and structured, primarily governed by the Code rural et de la pêche maritime. This legislation establishes that a veterinary diagnosis must be based on a clinical examination or health surveillance activities, ensuring that diagnostic decisions are made by qualified professionals. Laboratories performing official testing are required to maintain ISO/IEC 17025 accreditation through COFRAC. This framework is supported by a robust national surveillance system, with partnerships like the formal agreement between ANSES and GDS France strengthening epidemiological surveillance and supporting the prevention and control of animal diseases within a "One Health" approach.

Market Outlook
• According to the research report, "France Veterinary Reference Laboratory Market Overview, 2031," published by Bonafide Research, the France Veterinary Reference Laboratory Market is anticipated to grow at more than 8.33% CAGR from 2026 to 2031.
• A defining characteristic of the French market is the rapid modernization of diagnostic services, driven by technological advancements and the integration of molecular diagnostics. The adoption of PCR, next-generation sequencing, and other molecular techniques has accelerated, facilitating rapid pathogen identification and surveillance for conditions like antimicrobial resistance. The market benefits from the strong quality assurance framework maintained by COFRAC, which ensures diagnostic laboratories meet international standards. France is the EU's largest cattle producer, with a herd of 16.2 million. The partnership between ANSES and GDS France is a key element of the market, ensuring that research and surveillance efforts are closely aligned with the needs of livestock farmers and public health. This partnership has supported the development of eradication and sanitation programs for diseases like IBR and BVD.
• The market outlook reflects a strategic emphasis on the "One Health" approach, integrating animal health, food safety, and environmental health. ANSES's reference activities for diseases such as transmissible spongiform encephalopathies (TSE) and its role as an FAO Reference Centre for antimicrobial resistance highlight its international importance. A network of COFRAC-accredited laboratories across the country ensures that veterinary diagnostics are delivered to the highest standards. At the commercial level, global players such as IDEXX Laboratories, Zoetis, Neogen, and Merck KGaA, along with regional providers, maintain a significant presence, catering to the needs of both the companion animal and livestock sectors.



Market Dynamics

Driver: High and stable companion animal population and evolving pet ownership trends
The French veterinary reference laboratory market is significantly driven by a large and stable companion animal population, coupled with the ongoing trend of pet humanisation. France is home to approximately 73.4 million pets, with ownership present in 60% of households. Cats remain the most popular, with 16.6 million, followed by 9.6 million dogs. While the pet population saw a slight decline from 2024, it has grown by 14.6% compared to pre-pandemic 2018 levels, indicating a long-term upward trend. The total identified animal population (including dogs, cats, and ferrets) continues to grow, reaching 18.4 million by the end of 2025, even as new identifications slightly declined. This sustained population base, combined with the humanisation of pets where animals are increasingly considered family members drives demand for advanced diagnostics for preventive care and the management of chronic conditions. The companion animal segment accounted for 70.4% of the market in 2025, reflecting the significant economic weight of this sector.

Driver: Robust livestock sector and disease surveillance requirements
France's position as the EU's largest cattle producer, with a herd of 16.2 million cattle, continues to drive significant demand for veterinary diagnostic services. The livestock sector, which includes 3.6 million dairy cows , is a cornerstone of the French economy and its export market, requiring rigorous surveillance for diseases such as avian influenza and transmissible spongiform encephalopathies (TSE). The national reference laboratory network, coordinated by ANSES, conducts active disease surveillance and provides official diagnostic services to maintain animal health and protect international trade. A strategic partnership between ANSES and GDS France, formalised in February 2025, has been instrumental in developing and implementing diagnostic reference schemes for diseases like IBR, BVD, and paratuberculosis, which are critical for the health of the livestock industry and for maintaining the EU's acceptance of France's disease eradication programmes. This segment is forecast to experience the fastest growth, driven by the need for surveillance, export certifications, and herd health management.



Challenge: Livestock sector contraction and workforce shortages
Despite being the EU's leading cattle nation, the French livestock sector is experiencing a steady decline. Beef production fell by 2.6% in 2025, driven by a combination of disease-related pressures and a continuous reduction in the national herd. The dairy herd contracted by 2.5% between late 2024 and 2025 due to health crises like epizootic haemorrhagic disease (MHE) and bluetongue (FCO), and further reductions are expected. While average farm sizes may be increasing, the overall contraction in animal numbers can impact the volume of routine diagnostic testing. Another critical challenge is the limited availability of skilled veterinary professionals, particularly specialists in pathology and molecular diagnostics. Geographic disparities in access to advanced diagnostic services persist, with infrastructure concentrated in major agricultural and metropolitan regions.

Trend: Expansion of molecular diagnostics and integrated "One Health" surveillance networks
The French veterinary reference laboratory market is experiencing a significant shift towards molecular diagnostics and integrated surveillance networks. This is exemplified by ANSES's national high-speed sequencing platform, which provides advanced molecular diagnostic capabilities to support the rapid identification of pathogens. The Lyon Laboratory coordinates two major surveillance networks: RESAPATH, which monitors antimicrobial resistance in pathogenic bacteria of animal origin, and Vigimyc, which tracks ruminant mycoplasmas. These networks are central to the "One Health" approach, interlinking animal health, food safety, and public health data. Molecular diagnostics, such as PCR and ELISA, are increasingly being adopted for the detection of diseases like Peste des Petits Ruminants (PPR) and Rift Valley Fever (RVF), with COFRAC-accredited laboratories developing and validating these methods. This expansion of molecular testing is enabling faster and more accurate diagnoses, which is essential for effective outbreak management and antimicrobial stewardship.

Policies

• Code rural et de la pêche maritime Veterinary Diagnosis Provisions: This foundational legislation establishes that a veterinary diagnosis must be based on a clinical examination or health surveillance activities, ensuring that diagnostic decisions are made by qualified professionals. It prohibits veterinarians from establishing a diagnosis without prior clinical examination.
• COFRAC ISO/IEC 17025 Accreditation: The Comité français d'accréditation (COFRAC) is the sole national accreditation body in France, recognised internationally for assessing the technical competence of testing laboratories. Laboratories performing official veterinary diagnostic testing must maintain accreditation according to the NF EN ISO/CEI 17025 standard. This accreditation is a prerequisite for being designated as a National Reference Laboratory (NRL). As of 2024, the French Veterinary Services have established new laboratory authorisation procedures to further strengthen diagnostic capacity and ensure compliance with national and European standards.
• ANSES National Reference Laboratory (NRL) Network: ANSES operates a network of nine laboratories across 16 sites, performing reference and research activities in animal health and welfare, chemical and microbiological food safety, and plant health. The agency is at the heart of institutional networks for animal health and maintains direct links with the field for surveillance and emergency response. ANSES's Lyon Laboratory is the National Reference Laboratory for transmissible spongiform encephalopathies (TSE) , and its Ploufragan-Plouzané-Niort Laboratory holds NRL mandates for IBR and BVD.
• RESAPATH Antimicrobial Resistance Surveillance Network: Coordinated by ANSES's Lyon Laboratory, RESAPATH is the national surveillance network for antimicrobial resistance in pathogenic bacteria of animal origin. The network is a core component of France's national plan to reduce the use of antibiotics and monitor resistance trends in the livestock sector.
• ANSES and GDS France Partnership Framework: A formal agreement signed in February 2025 renewed and strengthened a long-standing partnership between ANSES and the French Federation of Health Protection Groups (GDS France). This partnership is critical for developing joint analytical reference and laboratory research activities, supporting epidemiological surveillance, and implementing disease prevention and control programmes as part of a "One Health" approach.

Segment Analysis

France Veterinary Reference Laboratory Market Overview, 2031 By Service Type
• Clinical Chemistry represents a significant revenue-generating service category in the French veterinary reference laboratory market. This segment is driven by routine blood chemistry panels and metabolic profiling tests used extensively in companion animal wellness checks and livestock health monitoring. The growing emphasis on preventive care and the early detection of disease in the large pet population supports demand for comprehensive chemistry panels.
• Immunodiagnostics is a critical and growing service category, encompassing ELISA-based testing, serological assays, and rapid test kits. This segment is vital for infectious disease screening, vaccine titer monitoring, and endocrine disorder diagnosis in both companion and livestock animals. COFRAC-accredited laboratories across the country, such as those belonging to the Bio Chêne Vert and Inovalys networks, are accredited to perform immunoserology tests for animal health, providing the diagnostic backbone for national surveillance programmes.
• Hematology maintains a strong presence within the market, driven by the fundamental need for complete blood count (CBC) analysis in routine and emergency veterinary medicine. This service is key for diagnosing anaemia, infection, and haematological abnormalities. The increasing incidence of chronic diseases in aging companion animals supports steady demand for haematology testing, which is a standard offering at most reference laboratories.
• Molecular Diagnostics represents the fastest-growing service category in the French market. This segment is experiencing significant expansion due to the adoption of PCR, next-generation sequencing, and digital PCR technologies. The development of molecular tests, such as those for Peste des Petits Ruminants (PPR) or Rift Valley Fever (RVF), is often carried out by accredited laboratories like Cirad's ASTRE unit, which then serves as a validation method for other official laboratories. Molecular diagnostics are central to surveillance networks like RESAPATH and enable rapid, precise pathogen identification and resistance profiling.
• Others encompasses microbiology, parasitology, toxicology, and anatomic pathology services. These specialised services are crucial for comprehensive diagnostic work-ups, particularly in livestock. Parasitology and microbiology remain essential for routine wellness screening, while anatomic pathology supports cancer diagnosis in companion animals. The COFRAC accreditation framework covers a wide range of these diagnostic services, including bacteriology, virology, and parasitology, ensuring high standards across the sector.

France Veterinary Reference Laboratory Market Overview, 2031 By Animal Type
• Companion Animals represent the largest revenue-generating segment, contributing approximately 70.4% of the French veterinary reference laboratory market in 2025. This dominance is driven by the country's high pet ownership rate (60% of households) and a large population of cats (16.6 million) and dogs (9.6 million). The strong humanisation trend and increasing investment in pet health are key growth factors. Even with a slight annual decline, the pet population remains significantly higher than pre-pandemic levels , and this stability drives consistent demand for diagnostic services.
• Production Animals represent a substantial and growing segment of the market and are forecast to experience the fastest growth during the forecast period. France is the EU's largest cattle producer, with a herd of 16.2 million animals , and has significant pig and poultry populations. The need for disease surveillance and herd health management drives demand for diagnostic services. Livestock producers and the national surveillance system rely on reference laboratories for early detection and control of diseases such as IBR and BVD. This segment is expected to see accelerated growth due to increased regulatory requirements for food safety, export certifications, and the ongoing need to maintain animal health amid structural changes and disease outbreaks.

France Veterinary Reference Laboratory Market Overview, 2031 By End User
• Veterinary Hospitals and Clinics are the largest end-user segment for reference laboratory services. Clinics across the country routinely outsource complex tests including advanced microbiology, histopathology, and molecular diagnostics that cannot be performed in-house. The large base of companion animal practitioners servicing the high pet population drives significant demand. The growth of specialty referral centres and corporate veterinary groups is leading to a more consolidated and standardised approach to laboratory purchasing.
• Research Institutes represent a significant end-user segment in France. This includes academic institutions like INRAE and the University of Lyon, which partner with ANSES, as well as veterinary schools and pharmaceutical research organisations. They rely on reference laboratories for advanced molecular testing, genetic analysis, and disease surveillance studies. The Cirad's ASTRE unit, for example, is a reference laboratory that develops and validates diagnostic methods used by official laboratories, bridging the gap between research and routine diagnostics. Research institutes are key drivers of the demand for high-complexity and cutting-edge diagnostic services.
• In-House Laboratories represent a complementary channel. While point-of-care testing is growing in popularity for rapid results, in-house laboratory capabilities are typically limited to routine haematology and basic chemistry. For complex, confirmatory, or high-volume testing, veterinary practices and large farms rely on reference laboratories. The in-house channel is primarily used to calculate the outsourcing rate, not double-counted as market revenue.

France Veterinary Reference Laboratory Procedure Economics
• Veterinary reference laboratory testing in France is a critical component of advanced veterinary care, requiring specialised equipment, highly trained personnel, and rigorous quality control. The economic model is built around a mix of public and private laboratories.
• Public Sector and National Reference Laboratories: ANSES, through its network of nine laboratories, is the cornerstone of the public diagnostic infrastructure. These laboratories are primarily government-funded, although they may offer fee-for-service testing for non-official surveillance.The cost of testing here is often subsidised as part of public health and epidemiological surveillance mandates.
• Commercial Reference Laboratories: Private commercial laboratories serve both the companion animal and livestock markets. They are accredited by COFRAC to perform a wide range of diagnostics, including serology, bacteriology, and molecular biology, ensuring their results are accepted for official purposes, including health certification. They provide services to veterinary hospitals and clinics across the country.
• Pricing and In-House Dynamics: In veterinary hospitals and clinics, the cost of a comprehensive diagnostic workup varies depending on the complexity of the test panel, the geographic location, and the specific laboratory pricing. Molecular diagnostic tests, such as PCR panels, represent a growing revenue source for reference laboratories. In-house testing represents a competitive channel for basic, routine diagnostics, particularly through point-of-care analyzers. Conversely, the high costs of advanced diagnostic equipment and the need for specialised expertise mean that reference laboratories remain the essential channel for specialized, high-complexity, and confirmatory testing. The expansion of COFRAC accreditation has strengthened private labs' capacity to replace or complement public and in-house testing for a broad range of needs, improving market access and competitiveness.


Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Veterinary Reference Laboratory Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Service Type
• Clinical Chemistry
• Hematology
• Immunodiagnostics
• Molecular Diagnostics
• Others

By Animal Type
• Companion Animals
• Livestock Animals

By End User
• Veterinary Hospitals and Clinics
• Research Institutes
• In-House Laboratories